Immunos Therapeutics is a privately held biotechnology company focused on harnessing the immune system to treat cancer and inflammatory diseases. The company develops immuno-oncology and immunomodulatory therapeutic candidates, advancing a preclinical and clinical pipeline supported by scientific and clinical advisory boards. Immunos Therapeutics is a portfolio company of Lightspeed Venture Partners. As a therapeutics/drug-development company it operates in the life sciences rather than as a software API provider, and publishes no public developer API, SDK, or developer documentation at this time. This profile is maintained in the API Evangelist network for company and portfolio discovery.
Immunos Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Immuno-Oncology, and Immunotherapy.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: immunos-therapeutics
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source: []
generated: '2026-07-22'
method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/immunos-therapeutics.png
name: Immunos Therapeutics
description: Immunos Therapeutics is a privately held biotechnology company focused on harnessing the immune system to treat
cancer and inflammatory diseases. The company develops immuno-oncology and immunomodulatory therapeutic candidates, advancing
a preclinical and clinical pipeline supported by scientific and clinical advisory boards. Immunos Therapeutics is a portfolio
company of Lightspeed Venture Partners. As a therapeutics/drug-development company it operates in the life sciences rather
than as a software API provider, and publishes no public developer API, SDK, or developer documentation at this time. This
profile is maintained in the API Evangelist network for company and portfolio discovery.
url: https://raw.githubusercontent.com/api-evangelist/immunos-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Immuno-Oncology
- Immunotherapy
- Inflammatory Diseases
- Drug Development
- Life Sciences
- Healthcare
apis: []
common:
- type: DomainSecurity
url: security/immunos-therapeutics-domain-security.yml
- type: Website
url: https://www.immunostherapeutics.com/
- type: Contact
url: https://www.immunostherapeutics.com/contact/
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
x-enrichment:
date: '2026-07-19'
status: backfilled
pass: local-v1
note: backfilled from .gitignore signal + verified work evidence
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.